Earnings call transcripts

Management framed the quarter as an operational ramp-up largely delivered, with open-pit grade and costs still needing improvement before steady-state performance.

Management framed the quarter as gradual improvement amid weaker markets, while shifting Nivea investment toward broader skincare and deodorants and tempering near-term expectations.

Management framed growth as portfolio-led and increasingly volume-driven, while acknowledging execution gaps in North American yogurt, creamers and plant-based products.

Management framed performance as resilient amid rate cuts, with lending growth and the structural hedge offsetting pressure while emphasizing disciplined execution of Forward 28.

Management framed Q3 as a seasonal trough, with stronger Q4 operations and cash flow supporting growth investment and higher shareholder returns.

Management framed the quarter as a return to strong execution after resolving HAPI-related distractions, with disciplined growth and renewed M&A activity now in focus.

Management framed Q3 as a broadening recovery powered by innovation, while cautioning that China and year-end demand remain hard to predict.

Management framed demand as mixed, with healthy service and pockets of strength offset by hesitant project customers, weak semiconductor spending and currency pressure.

Management framed another record quarter as consistent execution, with incremental growth increasingly dependent on finding an acquisition that meets strict return and dilution standards.

Management framed Q1 as a strong order quarter but emphasized uneven demand, lower-volume pressure, and restructuring rather than a broad-based recovery.

Management framed Q1 as evidence of cost control and improving stability, while emphasizing that growth and profitability remain dependent on execution and a volatile market.

Management framed Q4 as solid but emphasized that growth came against weak comparisons, while profitability reflected currency, one-offs, mix and ongoing investment.